J. K. Burmester

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing

Petra Lenzini, Mia Wadelius, Stephen Kimmel et al. · Clinical Pharmacology & Therapeutics · 2010 · 214 citations

Medicine, Pharmacology, Pharmacotherapy +16

A Prospective, Randomized Pilot Trial of Model-Based Warfarin Dose Initiation using CYP2C9 Genotype and Clinical Data

Michael A Hillman, Russell A. Wilke, Steven H. Yale et al. · Clinical Medicine & Research · 2005 · 196 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Inhibition of growth by transforming growth factor-beta following fusion of two nonresponsive human carcinoma cell lines. Implication of the type II receptor in growth inhibitory responses.

Andrew G. Geiser, J. K. Burmester, Renée Webbink et al. · Journal of Biological Chemistry · 1992 · 173 citations · Full text

Medicine, Cell Biology, Oncology +12

Evaluation of Genetic Factors for Warfarin Dose Prediction

Michael D. Caldwell, Richard L. Berg, K. Q. Zhang et al. · Clinical Medicine & Research · 2007 · 155 citations · Full text

Life Sciences, Genetics, Pharmacology +11

Isolation and expression of rat 1,25-dihydroxyvitamin D3 receptor cDNA.

J. K. Burmester, Nobuo Maeda, H. F. DeLuca · Proceedings of the National Academy of Sciences · 1988 · 132 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14